NCT04185220 2023-01-04Phase I Study of Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for People With Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sezary SyndromeNational Institutes of Health Clinical Center (CC)Phase 1 Completed6 enrolled 16 charts